← The Wire
ICUINasdaq
ICU MEDICAL INC/DE
Surgical & Medical Instruments & Apparatus · DE · CIK 883984
ICU Medical develops, manufactures, and sells medical products for infusion therapy, vascular access, and vital care
$3.55B
Market cap
$147.93
Last close
-0.2%
1D
+8.7%
5D
344K
Volume
Price · last 39 sessions+24.7%
May 4L $117.01 · H $148.83Jun 29
201
Total filings
May 18, 2026
Last filing
12/31
Fiscal year end
8-KBylaw Amendment · Shareholder VoteMay 18, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 2, 2026DEF 14ADEF 14AApr 2, 20268-KExecutive ChangeFeb 20, 202610-K10-KFeb 19, 20268-KResults of OperationsFeb 19, 202610-Q10-QNov 6, 20258-KResults of OperationsNov 6, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KExecutive Change · Shareholder VoteMay 14, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 3, 2025DEF 14ADEF 14AApr 3, 202510-K10-KFeb 27, 20258-KResults of OperationsFeb 27, 202510-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KExecutive ChangeOct 2, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KShareholder VoteMay 16, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 2, 2024DEF 14ADEF 14AApr 2, 20248-KExecutive ChangeFeb 29, 202410-K10-KFeb 27, 20248-KResults of OperationsFeb 27, 2024SC 13GSC 13GFeb 13, 202410-Q10-QNov 6, 20238-KResults of OperationsNov 6, 20238-KBylaw AmendmentNov 3, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 7, 20238-KExecutive Change · Shareholder VoteMay 22, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 8, 2023DEFA14ADEFA14AApr 4, 2023DEF 14ADEF 14AApr 4, 202310-K10-KFeb 27, 20238-KResults of OperationsFeb 27, 2023SC 13GSEC SCHEDULE 13GFeb 6, 20238-KExecutive ChangeJan 3, 202310-Q10-QNov 7, 20228-KResults of OperationsNov 7, 2022SC 13GSC 13GAug 10, 202210-Q10-QAug 9, 20228-KResults of OperationsAug 8, 20228-KShareholder VoteMay 18, 202210-Q10-QMay 9, 20228-KResults of OperationsMay 9, 20228-KExecutive ChangeApr 20, 2022DEFA14ADEFA14AApr 4, 2022DEF 14ADEF 14AApr 4, 20228-K/ACompany UpdateMar 21, 202210-K10-KFeb 25, 20228-KResults of OperationsFeb 24, 20228-KExecutive ChangeFeb 18, 20228-KExecutive ChangeFeb 1, 2022SC 13DSC 13DJan 12, 20228-KMaterial Agreement · Acquisition / DispositionJan 7, 20228-KExecutive ChangeJan 4, 202210-Q10-QNov 5, 20218-KResults of OperationsNov 3, 20218-KCompany UpdateSep 28, 20218-KMaterial Agreement · Reg FD DisclosureSep 8, 20218-KCompany UpdateAug 9, 202110-Q10-QAug 4, 20218-KResults of OperationsAug 4, 20218-KExecutive ChangeJul 7, 20218-KShareholder VoteMay 14, 202110-Q10-QMay 7, 20218-KResults of OperationsMay 6, 2021DEF 14ADEF 14AApr 1, 202110-K10-KFeb 26, 20218-KResults of OperationsFeb 25, 2021
Insider Activity
In the 90 days to Nov 25, 2025: 3 sold $754K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 25, 2025 | Woolson DanielVP, GM-Infusion Capital | Sell | 2,897 | $152.35 | $441K |
| Nov 11, 2025 | Finney Elisha WDirector | Sell | 1,285 | $140.42 | $180K |
| Nov 11, 2025 | Sanzone Virginia RuthVP, General Counsel | Sell | 930 | $142.35 | $132K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance